Thursday, January 28, 2021
2:54 AM
Reuters/Geneva
The World Health Organization said on Wednesday it had received data from Pfizer and BioNTech on the Covid-19 vaccine and was reviewing it for "possible listing for emergency use", a benchmark for countries to authorise national use.
Referring to Britain's regulator, the Medicines and Healthcare products Regulatory Agency, it said in a statement to Reuters: "WHO is also in discussions with MHRA on the possibility of accessing some of the information from their assessment, which could expedite WHO’s emergency listing".
Britain approved Pfizer's Covid-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the West's first country to formally endorse a shot it said should reach the most vulnerable people early next week.
Mike Ryan, WHO's top emergency expert, welcomed the news, adding: "We shouldn't stop, we need more than 3-4 vaccines
"We need to increase production, we need to pull the price down," he told a social media event. "We need a one-dose vaccine."
Air France and Airbus face Paris trial call over deadly crash
Dutch govt won’t bow to curfew rioters
UK PM takes full responsibility for Covid response
UK to unveil hotel quarantine plans, public told not to book vacations
Italy PM set to quit and seek new govt as pandemic rages
Estonia gets first female prime minister
Boeing 737 MAX to fly again in Europe, angering crash relatives
Portugal President Rebelo de Sousa wins new term in socially distanced ballot
Portugal stages poll with Covid protocols
1/27/2021 10:02:37 PM
1/27/2021 8:54:18 PM
1/27/2021 1:36:51 PM
There are no comments.